Ready to Use Therapeutic Food (RUTF) to Promote Growth in Cystic Fibrosis

Completed · Phase 1/Phase 2

Conditions studied: Cystic Fibrosis

In brief

Children with cystic fibrosis require increased caloric intake to maintain appropriate growth, an important determinant of long-term outcomes. This study seeks to determine the feasibility of using a novel therapeutic food to promote weight gain and growth in children with cystic fibrosis.

Key facts

Study ID

NCT03462056

Run by

Washington University School of Medicine

People needed

16

Starts

2018-05-17

Expected to finish

2019-06-14

Last updated by the study team

2019-06-20

Who can join

Age: 2 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cystic Fibrosis diagnosed by sweat test or genetic testing.
• Exocrine Pancreatic Insufficiency and receiving pancreatic enzyme replacement therapy
• BMI or weight for age of less than the 50th percentile

You may not qualify if…

• Cystic fibrosis related diabetes mellitus
• Cystic fibrosis related liver disease.
• Anaphylactic or other allergy to peanut, cow's milk, oat flour or other RUTF ingredients.
• Patients who are status-post lung or liver transplantation
• Currently receiving enteral supplemental nutrition through gastrostomy or nasogastric tube.

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.